40.04MMarket Cap-0.67P/E (TTM)
1.370High1.320Low151.96KVolume1.340Open1.350Pre Close203.30KTurnover1.05%Turnover RatioLossP/E (Static)29.88MShares22.22052wk High0.46P/B19.39MFloat Cap0.87052wk Low--Dividend TTM14.47MShs Float23.580Historical High--Div YieldTTM3.70%Amplitude0.870Historical Low1.337Avg Price1Lot Size
AN2 Therapeutics Stock Forum
I am in here for swing play. Chart looks good and insiders have been loading.
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (Caused by Mycobacterium Tuberculosis) and Malaria
Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
No comment yet